Atlas Trials

First in Human Study of the Infusion of ARI0003 Cells in Relapsed/Refractory to Treatment B-cell Aggressive Lymphoma

Clinical trial NCT06097455 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06097455
Sponsor
Fundacion Clinic per a la Recerca Biomédica
Status
NOT_YET_RECRUITING
Phase
Early Phase 1
Study type
INTERVENTIONAL
Refractory Non-Hodgkin LymphomaRelapsed Non-Hodgkin Lymphoma
Start date
2024-01-15
Primary completion
2025-04-15
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.